Annovis Bio, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Annovis Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q2 2024.
  • Annovis Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$5.02M, a 47.4% increase year-over-year.
  • Annovis Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$43M, a 28.7% decline year-over-year.
  • Annovis Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$56.2M, a 122% decline from 2022.
  • Annovis Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$25.3M, a 74.8% decline from 2021.
  • Annovis Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$14.5M, a 165% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$43M -$5.02M +$4.52M +47.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$47.5M -$1.07M +$8.67M +89% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-14
Q4 2023 -$56.2M -$22.2M -$14.5M -188% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$41.7M -$14.7M -$8.28M -129% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$33.4M -$9.54M -$3.6M -60.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$29.8M -$9.74M -$4.5M -86% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-14
Q4 2022 -$25.3M -$7.73M -$1.81M -30.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$23.5M -$6.43M -$3.58M -126% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$19.9M -$5.94M -$3.41M -135% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 -$16.5M -$5.23M -$2.03M -63.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-08
Q4 2021 -$14.5M -$5.91M -$4.21M -247% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$10.3M -$2.85M -$1.84M -183% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$8.44M -$2.52M -$215K -9.31% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$8.22M -$3.2M -$2.76M -625% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$5.46M -$1.7M -$1.5M -747% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-02
Q3 2020 -$3.96M -$1.01M -$752K -296% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$3.21M -$2.31M -$1.96M -570% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-03
Q1 2020 -$1.24M -$442K -$251K -131% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-03
Q4 2019 -$991K -$201K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-03
Q3 2019 -$254K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$345K Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-04
Q1 2019 -$191K Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.